title: Detection of prokaryotic mRNA signifies microbial viability and promotes immunity.
abstract: Live vaccines have long been known to trigger far more vigorous immune responses than their killed counterparts. This has been attributed to the ability of live microorganisms to replicate and express specialized virulence factors that facilitate invasion and infection of their hosts. However, protective immunization can often be achieved with a single injection of live, but not dead, attenuated microorganisms stripped of their virulence factors. Pathogen-associated molecular patterns (PAMPs), which are detected by the immune system, are present in both live and killed vaccines, indicating that certain poorly characterized aspects of live microorganisms, not incorporated in dead vaccines, are particularly effective at inducing protective immunity. Here we show that the mammalian innate immune system can directly sense microbial viability through detection of a special class of viability-associated PAMPs (vita-PAMPs). We identify prokaryotic messenger RNA as a vita-PAMP present only in viable bacteria, the recognition of which elicits a unique innate response and a robust adaptive antibody response. Notably, the innate response evoked by viability and prokaryotic mRNA was thus far considered to be reserved for pathogenic bacteria, but we show that even non-pathogenic bacteria in sterile tissues can trigger similar responses, provided that they are alive. Thus, the immune system actively gauges the infectious risk by searching PAMPs for signatures of microbial life and thus infectivity. Detection of vita-PAMPs triggers a state of alert not warranted for dead bacteria. Vaccine formulations that incorporate vita-PAMPs could thus combine the superior protection of live vaccines with the safety of dead vaccines.
authors: Immunology Institute, Department of Medicine, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, New York 10029, USA.
authors: Leif E
authors: LE
authors: Sander
authors: Michael J
authors: MJ
authors: Davis
authors: Mark V
authors: MV
authors: Boekschoten
authors: Derk
authors: D
authors: Amsen
authors: Christopher C
authors: CC
authors: Dascher
authors: Bernard
authors: B
authors: Ryffel
authors: Joel A
authors: JA
authors: Swanson
authors: Michael
authors: M
authors: Müller
authors: J Magarian
authors: JM
authors: Blander
references: Nat Immunol. 2008 Aug;9(8):847-56
references: 18604214
references: Science. 2010 Jan 15;327(5963):284-6
references: 20075242
references: Cell. 2010 Mar 19;140(6):805-20
references: 20303872
references: Nat Rev Immunol. 2007 Jan;7(1):31-40
references: 17186029
references: Cell Host Microbe. 2010 Jan 21;7(1):38-49
references: 20114027
references: Immunity. 2000 Oct;13(4):539-48
references: 11070172
references: Microb Cell Fact. 2006 Jun 23;5:23
references: 16796731
references: Methods Enzymol. 2006;411:134-93
references: 16939790
references: Nat Rev Microbiol. 2010 Dec;8(12):857-66
references: 21079634
references: Nature. 2009 Mar 5;458(7234):78-82
references: 19262671
references: Trends Microbiol. 1996 Nov;4(11):453-5
references: 8950815
references: Immunity. 2005 Aug;23(2):165-75
references: 16111635
references: Trends Immunol. 2011 Jan;32(1):34-41
references: 21147034
references: Nat Rev Mol Cell Biol. 2010 Jul;11(7):467-78
references: 20520623
references: Nat Rev Microbiol. 2008 Jan;6(1):53-66
references: 18026123
references: Cell. 2010 Mar 19;140(6):821-32
references: 20303873
references: Nucleic Acids Res. 2005 Nov 10;33(20):e175
references: 16284200
references: Nat Med. 2005 Aug;11(8):853-60
references: 16041382
references: Nature. 2006 Mar 9;440(7081):233-6
references: 16407888
references: Nucleic Acids Res. 2003 Feb 15;31(4):e15
references: 12582260
references: J Immune Based Ther Vaccines. 2006 Oct 23;4:5
references: 17059608
references: Microbes Infect. 2007 Aug;9(10):1176-87
references: 17720603
references: BMC Bioinformatics. 2006 Dec 19;7:538
references: 17177995
references: Immunity. 2006 Mar;24(3):317-27
references: 16546100
references: Oncogene. 1999 Nov 22;18(49):6853-66
references: 10602461
references: PLoS Pathog. 2007 Mar;3(3):e51
references: 17397264
references: Science. 2001 Nov 23;294(5547):1735-9
references: 11721060
references: Nucleic Acids Res. 2008 Jan;36(Database issue):D178-83
references: 17947322
references: Biotechniques. 2003 Feb;34(2):374-8
references: 12613259
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D852-7
references: 18996892
references: Science. 2010 Jun 25;328(5986):1703-5
references: 20508090
references: RNA Biol. 2008 Jul-Sep;5(3):140-4
references: 18769134
references: Infect Immun. 1985 Jul;49(1):164-71
references: 2989179
references: Science. 1995 Mar 31;267(5206):2000-3
references: 7535475
references: Science. 2004 May 14;304(5673):1014-8
references: 15143282
references: Genome Biol. 2004;5(10):R80
references: 15461798
references: Cell Host Microbe. 2009 Jul 23;6(1):10-21
references: 19616762
references: Nature. 1982 May 20;297(5863):233-4
references: 6176874
references: PLoS Pathog. 2009 Nov;5(11):e1000665
references: 19936053
references: Infect Immun. 1994 Oct;62(10):4396-403
references: 7927701
references: J Leukoc Biol. 2010 Oct;88(4):813-22
references: 20587739
references: Nucleic Acids Res. 2010 Sep;38(17):5884-92
references: 20457754
references: Cell. 2006 Feb 24;124(4):703-14
references: 16497582
references: J Bacteriol. 2004 Feb;186(3):699-705
references: 14729695
references: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
references: 12883005
references: J Innate Immun. 2010;2(5):406-21
references: 20505309
references: Bioinformatics. 2003 Jan 22;19(2):185-93
references: 12538238
references: Science. 1990 May 11;248(4956):730-2
references: 1970672
references: Science. 2006 Nov 10;314(5801):994-7
references: 17038590
references: Immunity. 2009 Jun 19;30(6):766-75
references: 19538928
references: Nature. 2011 Jan 13;469(7329):221-5
references: 21124315